Call Us Toll Free: 1-800-388-9993

 

A reliable investment strategy: Identify a widely diversified portfolio of high-quality stocks and build up additional holdings at favorable prices.

 

DRIPs can help you do that.

 

Even small investors can follow such a strategy by investing through dividend reinvestment plans (DRIPs). That's because it takes ownership of only a single share of company stock to establish an account. Therefore, there is nothing to stop you from buying companies in a variety of industries.

 

As for buying at favorable prices, dollar-cost averaging virtually assures that you will buy most shares at favorable prices. And DRIPs provide an excellent way to dollar-cost average. These plans allow you to invest cash amounts to buy shares directly from the company. Once you are enrolled in a plan, you can invest amounts of as little as $25 or $50 (or as much as you can afford) to buy shares or fractions of shares. That's different than the traditional way to invest, which is to pay brokerage fees to buy a certain number of shares.

 

 

Sanofi American Depositary (SNY)

Available from the Temper Enrollment Service: Yes


Last Update On: 01/28/2020:

Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1 and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. It also provides Dupixent for atopic dermatitis Kevzara for rheumatoid arthritis Eloctate and Alprolix to treat hemophilia and Cablivi to treat acquired thrombotic thrombocytopenic purpura. In addition, it offers Libtayo for metastatic cutaneous squamous cell carcinoma Jevtana and Taxotere taxane for cancers Eloxatin for colon cancer Thymoglobulin, an immunosuppressive and immunomodulating agent Mozobil, for hematologic malignancies and Zaltrap, for metastatic colorectal cancer. Further, it provides Lantus, Toujeo, Apidra, and Insuman insulins Amaryl sulfonylurea Adlyxin/Lyxumia, a GLP-1 receptor agonist Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes Admelog/Insulin lispro insulin Praluent, a cholesterol-lowering drug and Multaq, an anti-arrhythmic drug for atrial fibrillation. Additionally, it offers Plavix for atherothrombotic conditions Lovenox for the prophylaxis, venous thromboembolism, and acute coronary syndrome Aprovel and CoAprovel anti-hypertensives Renagel and Renvela for patients undergoing dialysis Synvisc and Synvisc-One viscosupplements for osteoarthritis Stilnox for insomnia Allegra for seasonal allergic rhinitis and uncomplicated hives and Depakine for epilepsy. It also provides generic products and products for allergy, cough, cold, pain, nutrition, digestion, pediatrics, influenza, meningitis, travel, and endemic vaccines and adult and adolescent boosters. Sanofi has an alliance with Verily Life Sciences LLC and agreement with Happify Health. Sanofi was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France. **Taken from Yahoo Finance**

Industry: Drugs
Minimum Investment: $50.00
Maximum Investment: $100,000/year
Shares to qualify: 1
Recent Price: 45.46
Investing Fee: $0.00
Fee for Dividends: $0.00

! = Company pays fees

Information is based on an annual survey and updated when company changes become available.

Click for Español

FOR MORE
INFORMATION

And a free copy of The Moneypaper's direct investing brochure, please enter your contact information below.

You will also be signed up to receive our monthly stock special.

You can unsubscribe at any time. We do not share your email with anyone.

By email, you get the Monthly “Stock Special,” where the service fee for enrollment in a great DRIP stock is reduced.

* Required Field.